Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

C4 Therapeutics (CCCC) Tax Provisions: 2019-2024

Historic Tax Provisions for C4 Therapeutics (CCCC) over the last 4 years, with Dec 2024 value amounting to $131,000.

  • C4 Therapeutics' Tax Provisions fell 52.71% to $131,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $1.3 million, marking a year-over-year increase of 30.13%. This contributed to the annual value of $131,000 for FY2024, which is 89.77% down from last year.
  • As of FY2024, C4 Therapeutics' Tax Provisions stood at $131,000, which was down 89.77% from $1.3 million recorded in FY2023.
  • In the past 5 years, C4 Therapeutics' Tax Provisions ranged from a high of $1.3 million in FY2023 and a low of -$626,000 during FY2020.
  • For the 2-year period, C4 Therapeutics' Tax Provisions averaged around $705,500, with its median value being $705,500 (2023).
  • Data for C4 Therapeutics' Tax Provisions shows a maximum YoY tumbled of 177.86% (in 2020) over the last 5 years.
  • Yearly analysis of 3 years shows C4 Therapeutics' Tax Provisions stood at -$626,000 in 2020, then reached $1.3 million in 2023, then slumped by 89.77% to $131,000 in 2024.